Cancer Research ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
| | | | Juanita Lopez, Christina Yap and Richard Mair are designing a new clinical trial to find better treatments for brain cancer.
The 5G platform trial is a UK-wide adaptive platform trial funded by us and the Minderoo Foundation to test multiple treatments for people living with glioma.
The drug combination a patient receives will be based on the specific genetic makeup of their cancer. The use of the whole genome sequencing for every patient on the trial performed will enable a more agile and precise drug targeting approach.
“The 5G platform trial presents a unique opportunity to work in new and exciting ways to find better treatment options for this patient population,” says Juanita Lopez from The Institute of Cancer Research.
This project received an Experimental Medicine Award from our Clinical Research Committee. We’ve now replaced this, along with all other existing clinical research funding schemes, with our new module-based funding scheme. The scheme supports high-quality research that addresses key clinical questions whilst deepening our understanding of cancer biological mechanisms. |
| | |
| | |
|
|
|
|
Funding & Research Opportunities |
| Get in touch with our office for confidential advice on eligibility, remit and funding options prior to applying. |
|
| | | | | | Applications accepted all year round |
|
|---|
| | | | | | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
|
| | |
|
|
Antonis Antoniou wins Don Listwin Award |
| Congratulations to Professor Antonis Antoniou for winning the Don Listwin Award in recognition of his contributions to the field of early cancer detection.
Yesterday at our Early Detection of Cancer conference, we proudly recognised Antonis’ and his team’s work on understanding cancer risks for genetically susceptible individuals, statistical techniques for modelling cancer susceptibility and the development of risk prediction tools for clinical use.
"I’m deeply honoured that our team’s work, particularly on breast and ovarian cancer risk prediction models and tools, is being recognised with this award. These advancements empower informed decisions on cancer screening and prevention," said Antonis from the University of Cambridge. |
| | |
|
|
|
#ResearchIsBeautiful: last chance to submit your entries for this month |
| Have you entered your research image yet?
Our image campaign invites you to share your perspective, your passion and your research into cancer research with us. Have a sneak peek at our selections of past entries, and don’t forget to email us your image today. |
| | |
|
|
|
| | | | | Are you looking for the next step in your academic or clinical career?
Applications are now open for the fully funded Cancer Research UK Manchester Centre PhD Scheme. Opportunities are available across various cancer disciplines, and you can choose from three different PhD pathways:
• Non-Clinical Studentships
• Clinical Research Training Fellowships
• Leeds-Manchester Clinical Research Training Fellowship
| | |
| | | | | | | Target product profiles (TPPs) could support innovation by laying out and aligning what health systems need from new diagnostic tests, therefore helping new tests reach patients faster.
In our recent Cancer News article, we discussed our TPP activity from the progress we've made already to our next steps.
Hear from our funded researcher Bethany Shinkins from the University of Warwick on her project and the promise of TPPs in practice. | | |
|
|---|
|
|
|
|
| | Pictures that speak a thousand words |
| | Advancements in radiomics, deep learning and AI pathological approaches are enabling a novel method of classifying responses from rectal cancer patients to chemoradiotherapy.
We spoke to Joanne Edwards from our Scotland Centre about the new project she’s co-leading that will use these advancements to enhance classification methods, integrating radiomics with other data such as clinical, pathological and genomic to inform the management of rectal cancer.
This project will see researchers, surgeons and engineers collaborate to convert scan images into high-dimensional data for analysis to support clinical decision-making and new drug development. |
| | |
|
|
|---|
|
|
|
|
|
| | Together we are
beating cancer |
| | |
|---|
|
|
|
| | | You are playing a crucial role in helping us beat cancer, so we'd like to continue to keep you updated on what we're up to. You can manage your preferences and unsubscribe here.
Your details are safe with us. Check out our Privacy Policy.
Our supporters are at the heart of everything we achieve at Cancer Research UK. Read our Fundraising Promise.
This email is from Cancer Research UK. Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ. |
|
|
|
